$ARYX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARYx Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ARYx Therapeutics, Inc.. Get notifications about new insider transactions in ARYx Therapeutics, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 14 2011 | ARYX | ARYx Therapeutics, ... | Growth Equity Opportunities Fu ... | 10% Owner | Sell | S | 0.07 | 4,469,274 | 326,257 | 0 | 4.5 M to 0 (-100.00 %) |
Mar 14 2011 | ARYX | ARYx Therapeutics, ... | Growth Equity Opportunities Fu ... | 10% Owner | Sell | S | 0.07 | 4,469,274 | 326,257 | 0 | 4.5 M to 0 (-100.00 %) |
Mar 14 2011 | ARYX | ARYx Therapeutics, ... | DRANT RYAN D | 10% Owner | Sell | S | 0.07 | 4,469,274 | 326,257 | 0 | 4.5 M to 0 (-100.00 %) |
Mar 14 2011 | ARYX | ARYx Therapeutics, ... | BASKETT FOREST | 10% Owner | Sell | S | 0.07 | 4,469,274 | 326,257 | 0 | 4.5 M to 0 (-100.00 %) |
Mar 14 2011 | ARYX | ARYx Therapeutics, ... | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 0.07 | 4,469,274 | 326,257 | 0 | 4.5 M to 0 (-100.00 %) |
Mar 14 2011 | ARYX | ARYx Therapeutics, ... | KERINS PATRICK J | 10% Owner | Sell | S | 0.07 | 4,469,274 | 326,257 | 0 | 4.5 M to 0 (-100.00 %) |
Oct 04 2010 | ARYX | ARYx Therapeutics, ... | SIMON NICHOLAS J III | Director | Option Exercise | P | 0.50 | 500,000 | 250,000 | 500,000 | |
Oct 04 2010 | ARYX | ARYx Therapeutics, ... | MPM BIOVENTURES III-QP L.P. | 10% Owner | Option Exercise | P | 0.50 | 500,000 | 250,000 | 500,000 | |
Oct 04 2010 | ARYX | ARYx Therapeutics, ... | EVNIN LUKE | 10% Owner | Option Exercise | P | 0.50 | 500,000 | 250,000 | 500,000 | |
Aug 17 2010 | ARYX | ARYx Therapeutics, ... | EVNIN LUKE | 10% Owner | Option Exercise | P | 0.50 | 500,000 | 250,000 | 500,000 | |
Aug 17 2010 | ARYX | ARYx Therapeutics, ... | MPM BIOVENTURES III-QP L.P. | 10% Owner | Option Exercise | P | 0.50 | 500,000 | 250,000 | 500,000 | |
Aug 17 2010 | ARYX | ARYx Therapeutics, ... | SIMON NICHOLAS J III | Director | Option Exercise | P | 0.50 | 500,000 | 250,000 | 500,000 | |
May 03 2010 | ARYX | ARYx Therapeutics, ... | Ekman Lars | Director | Option Exercise | A | 0.88 | 6,666 | 5,866 | 6,666 | |
May 03 2010 | ARYX | ARYx Therapeutics, ... | Leonard Keith R | Director | Option Exercise | A | 0.88 | 6,666 | 5,866 | 6,666 | |
May 03 2010 | ARYX | ARYx Therapeutics, ... | ROSENMAN HERM | Director | Option Exercise | A | 0.88 | 6,666 | 5,866 | 6,666 | |
May 03 2010 | ARYX | ARYx Therapeutics, ... | SIMON NICHOLAS J III | Director | Option Exercise | A | 0.88 | 6,666 | 5,866 | 6,666 | |
May 03 2010 | ARYX | ARYx Therapeutics, ... | SEKHRI PAUL J | Director | Option Exercise | A | 0.88 | 6,666 | 5,866 | 6,666 | |
May 03 2010 | ARYX | ARYx Therapeutics, ... | BEIER DAVID W | Director | Option Exercise | A | 0.88 | 6,666 | 5,866 | 6,666 | |
Mar 19 2010 | ARYX | ARYx Therapeutics, ... | Barker Jason | Sr.Dir.& Principal ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Mar 02 2010 | ARYX | ARYx Therapeutics, ... | Nagler David | V.P.,Corp. Affairs ... | Option Exercise | A | 0.00 | 130,000 | 0 | 130,000 | |
Mar 01 2010 | ARYX | ARYx Therapeutics, ... | Druzgala Pascal | Sr. V.P. & Chief Sc ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Mar 01 2010 | ARYX | ARYx Therapeutics, ... | Varian John | COO & CFO | Option Exercise | A | 0.00 | 160,000 | 0 | 160,000 | |
Mar 01 2010 | ARYX | ARYx Therapeutics, ... | Milner Peter G | Pres., Research & D ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Mar 01 2010 | ARYX | ARYx Therapeutics, ... | GODDARD PAUL | Chairman & CEO | Option Exercise | A | 0.00 | 250,000 | 0 | 250,000 | |
Aug 19 2009 | ARYX | ARYx Therapeutics, ... | Druzgala Pascal | Sr. V.P. & Chief Sc ... | Sell | J | 0.00 | 8,982 | 0 | 0 | 9 K to 0 (-100.00 %) |
Aug 19 2009 | ARYX | ARYx Therapeutics, ... | Druzgala Pascal | Sr. V.P. & Chief Sc ... | Sell | J | 0.00 | 8,982 | 0 | 0 | 9 K to 0 (-100.00 %) |
May 26 2009 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | P | 2.64 | 364,395 | 962,003 | 364,395 | |
May 26 2009 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 4.00 | 2,000,000 | 8,000,000 | 1,340,139 | 3.3 M to 1.3 M (-59.88 %) |
May 01 2009 | ARYX | ARYx Therapeutics, ... | SIMON NICHOLAS J III | Director | Option Exercise | A | 3.80 | 6,666 | 25,331 | 6,666 | |
May 01 2009 | ARYX | ARYx Therapeutics, ... | Ekman Lars | Director | Option Exercise | A | 3.80 | 6,666 | 25,331 | 6,666 | |
May 01 2009 | ARYX | ARYx Therapeutics, ... | Leonard Keith R | Director | Option Exercise | A | 3.80 | 6,666 | 25,331 | 6,666 | |
May 01 2009 | ARYX | ARYx Therapeutics, ... | Leonard Keith R | Director | Option Exercise | A | 3.80 | 6,666 | 25,331 | 6,666 | |
May 01 2009 | ARYX | ARYx Therapeutics, ... | ROSENMAN HERM | Director | Option Exercise | A | 3.80 | 6,666 | 25,331 | 6,666 | |
May 01 2009 | ARYX | ARYx Therapeutics, ... | SEKHRI PAUL J | Director | Option Exercise | A | 3.80 | 6,666 | 25,331 | 6,666 | |
May 01 2009 | ARYX | ARYx Therapeutics, ... | BEIER DAVID W | Director | Option Exercise | A | 3.80 | 6,666 | 25,331 | 6,666 | |
Feb 20 2009 | ARYX | ARYx Therapeutics, ... | Barker Jason | Sr.Dir.& Principal ... | Option Exercise | A | 2.70 | 9,893 | 26,711 | 9,893 | |
Feb 20 2009 | ARYX | ARYx Therapeutics, ... | Canafax Daniel | V.P. & CDO | Option Exercise | A | 2.70 | 40,000 | 108,000 | 40,000 | |
Feb 20 2009 | ARYX | ARYx Therapeutics, ... | Nagler David | V.P.,Corp. Affairs ... | Option Exercise | A | 2.70 | 60,000 | 162,000 | 60,000 | |
Feb 20 2009 | ARYX | ARYx Therapeutics, ... | Druzgala Pascal | Sr. V.P. & Chief Sc ... | Option Exercise | A | 2.70 | 60,000 | 162,000 | 60,000 | |
Feb 20 2009 | ARYX | ARYx Therapeutics, ... | Milner Peter G | Pres., Research & D ... | Option Exercise | A | 2.70 | 90,000 | 243,000 | 90,000 | |
Feb 20 2009 | ARYX | ARYx Therapeutics, ... | Varian John | COO & CFO | Option Exercise | A | 2.70 | 100,000 | 270,000 | 100,000 | |
Feb 20 2009 | ARYX | ARYx Therapeutics, ... | GODDARD PAUL | Chairman & CEO | Option Exercise | A | 2.70 | 200,000 | 540,000 | 200,000 | |
Nov 18 2008 | ARYX | ARYx Therapeutics, ... | Adelman Robert J | Director | Option Exercise | P | 2.64 | 364,395 | 962,003 | 364,395 | |
Nov 18 2008 | ARYX | ARYx Therapeutics, ... | Adelman Robert J | Director | Buy | P | 0.00 | 1,214,646 | 0 | 3,340,139 | 2.1 M to 3.3 M (+57.15 %) |
Nov 18 2008 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | P | 2.64 | 364,395 | 962,003 | 364,395 | |
Nov 18 2008 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 0.00 | 1,214,646 | 0 | 3,340,139 | 2.1 M to 3.3 M (+57.15 %) |
Nov 17 2008 | ARYX | ARYx Therapeutics, ... | MPM BIOVENTURES III QP LP | 10% Owner | Option Exercise | P | 2.64 | 536,313 | 1,415,866 | 536,313 | |
Nov 17 2008 | ARYX | ARYx Therapeutics, ... | MPM BIOVENTURES III QP LP | 10% Owner | Buy | P | 2.20 | 1,787,710 | 3,932,962 | 5,364,572 | 3.6 M to 5.4 M (+49.98 %) |
Nov 17 2008 | ARYX | ARYx Therapeutics, ... | SIMON NICHOLAS J III | Director | Option Exercise | P | 2.64 | 536,313 | 1,415,866 | 536,313 | |
Nov 17 2008 | ARYX | ARYx Therapeutics, ... | SIMON NICHOLAS J III | Director | Buy | P | 2.20 | 1,787,710 | 3,932,962 | 5,364,572 | 3.6 M to 5.4 M (+49.98 %) |
Nov 17 2008 | ARYX | ARYx Therapeutics, ... | EVNIN LUKE | 10% Owner | Option Exercise | P | 2.64 | 536,313 | 1,415,866 | 536,313 | |
Nov 17 2008 | ARYX | ARYx Therapeutics, ... | EVNIN LUKE | 10% Owner | Buy | P | 2.20 | 1,787,710 | 3,932,962 | 5,364,572 | 3.6 M to 5.4 M (+49.98 %) |
Oct 28 2008 | ARYX | ARYx Therapeutics, ... | Druzgala Pascal | V.P. & Chief Scient ... | Sell | J | 0.00 | 7,684 | 0 | 8,982 | 16.7 K to 9 K (-46.11 %) |
Oct 28 2008 | ARYX | ARYx Therapeutics, ... | Druzgala Pascal | V.P. & Chief Scient ... | Sell | J | 0.00 | 7,684 | 0 | 8,982 | 16.7 K to 9 K (-46.11 %) |
Sep 02 2008 | ARYX | ARYx Therapeutics, ... | BEIER DAVID W | Director | Option Exercise | A | 6.33 | 16,666 | 105,496 | 16,666 | |
Feb 15 2008 | ARYX | ARYx Therapeutics, ... | Barker Jason | Sr.Dir.& Principal ... | Option Exercise | A | 7.55 | 8,833 | 66,689 | 8,833 | |
Feb 07 2008 | ARYX | ARYx Therapeutics, ... | Nagler David | V.P. Corp. Affairs ... | Option Exercise | A | 7.55 | 30,000 | 226,500 | 30,000 | |
Feb 07 2008 | ARYX | ARYx Therapeutics, ... | Canafax Daniel | V.P. & CDO | Option Exercise | A | 7.55 | 60,000 | 453,000 | 60,000 | |
Feb 07 2008 | ARYX | ARYx Therapeutics, ... | Druzgala Pascal | V.P. & Chief Scient ... | Option Exercise | A | 7.55 | 35,000 | 264,250 | 35,000 | |
Feb 07 2008 | ARYX | ARYx Therapeutics, ... | Varian John | COO & CFO | Option Exercise | A | 7.55 | 44,000 | 332,200 | 44,000 | |
Feb 07 2008 | ARYX | ARYx Therapeutics, ... | Milner Peter G | Pres., Research & D ... | Option Exercise | A | 7.55 | 40,000 | 302,000 | 40,000 | |
Feb 07 2008 | ARYX | ARYx Therapeutics, ... | GODDARD PAUL | Chairman & CEO | Option Exercise | A | 7.55 | 100,000 | 755,000 | 100,000 | |
Nov 15 2007 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 323,399 | 0 | 0 | |
Nov 15 2007 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 604,228 | 0 | 0 | |
Nov 15 2007 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 897,866 | 0 | 0 | |
Nov 15 2007 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | P | 10.00 | 300,000 | 3,000,000 | 2,125,493 | 1.8 M to 2.1 M (+16.43 %) |
Nov 15 2007 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,825,493 | 0 | 1,825,493 | 0 to 1.8 M |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Milner Peter G | Pres., Research & D ... | Option Exercise | C | 0.00 | 14,409 | 0 | 0 | |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Milner Peter G | Pres., Research & D ... | Option Exercise | C | 0.00 | 3,393 | 0 | 0 | |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Milner Peter G | Pres., Research & D ... | Option Exercise | C | 0.00 | 16,835 | 0 | 0 | |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Milner Peter G | Pres., Research & D ... | Option Exercise | C | 0.00 | 416 | 0 | 0 | |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Milner Peter G | Pres., Research & D ... | Option Exercise | C | 0.00 | 416 | 0 | 0 | |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Milner Peter G | Pres., Research & D ... | Option Exercise | C | 0.00 | 1,683 | 0 | 0 | |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Milner Peter G | Pres., Research & D ... | Option Exercise | C | 0.00 | 10,101 | 0 | 0 | |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Milner Peter G | Pres., Research & D ... | Buy | C | 0.00 | 14,409 | 0 | 31,903 | 17.5 K to 31.9 K (+82.37 %) |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Milner Peter G | Pres., Research & D ... | Buy | C | 0.00 | 3,393 | 0 | 4,052 | 659 to 4.1 K (+514.87 %) |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Milner Peter G | Pres., Research & D ... | Buy | C | 0.00 | 16,835 | 0 | 17,494 | 659 to 17.5 K (+2,554.63 %) |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Milner Peter G | Pres., Research & D ... | Buy | C | 0.00 | 659 | 0 | 659 | 0 to 659 |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Milner Peter G | Pres., Research & D ... | Buy | C | 0.00 | 659 | 0 | 659 | 0 to 659 |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Milner Peter G | Pres., Research & D ... | Buy | C | 0.00 | 1,683 | 0 | 287,617 | 285.9 K to 287.6 K (+0.59 %) |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Milner Peter G | Pres., Research & D ... | Buy | C | 0.00 | 10,101 | 0 | 285,934 | 275.8 K to 285.9 K (+3.66 %) |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | GODDARD PAUL | Chairman & CEO | Option Exercise | C | 0.00 | 3,021 | 0 | 0 | |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | GODDARD PAUL | Chairman & CEO | Buy | C | 0.00 | 3,021 | 0 | 57,187 | 54.2 K to 57.2 K (+5.58 %) |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Adelman Robert J | Director | Option Exercise | C | 0.00 | 323,399 | 0 | 0 | |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Adelman Robert J | Director | Option Exercise | C | 0.00 | 604,228 | 0 | 0 | |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Adelman Robert J | Director | Option Exercise | C | 0.00 | 897,866 | 0 | 0 | |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Adelman Robert J | Director | Buy | C | 0.00 | 323,399 | 0 | 2,125,493 | 1.8 M to 2.1 M (+17.95 %) |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Adelman Robert J | Director | Buy | C | 0.00 | 604,228 | 0 | 1,802,094 | 1.2 M to 1.8 M (+50.44 %) |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Adelman Robert J | Director | Buy | C | 0.00 | 897,866 | 0 | 1,197,866 | 300 K to 1.2 M (+299.29 %) |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Adelman Robert J | Director | Buy | P | 10.00 | 300,000 | 3,000,000 | 300,000 | 0 to 300 K |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Druzgala Pascal | V.P. & Chief Scient ... | Option Exercise | C | 0.00 | 1,122 | 0 | 0 | |
Nov 14 2007 | ARYX | ARYx Therapeutics, ... | Druzgala Pascal | V.P. & Chief Scient ... | Buy | C | 0.00 | 1,122 | 0 | 205,288 | 204.2 K to 205.3 K (+0.55 %) |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | SIMON NICHOLAS J III | Director | Option Exercise | C | 0.00 | 580,518 | 0 | 0 | |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | SIMON NICHOLAS J III | Director | Option Exercise | C | 0.00 | 1,125,077 | 0 | 0 | |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | SIMON NICHOLAS J III | Director | Option Exercise | C | 0.00 | 1,571,267 | 0 | 0 | |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | SIMON NICHOLAS J III | Director | Option Exercise | C | 0.00 | 2,777 | 0 | 0 | |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | SIMON NICHOLAS J III | Director | Buy | P | 10.00 | 300,000 | 3,000,000 | 3,576,862 | 3.3 M to 3.6 M (+9.16 %) |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | SIMON NICHOLAS J III | Director | Buy | C | 0.00 | 580,518 | 0 | 3,276,862 | 2.7 M to 3.3 M (+21.53 %) |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | SIMON NICHOLAS J III | Director | Buy | C | 0.00 | 1,125,077 | 0 | 2,696,344 | 1.6 M to 2.7 M (+71.60 %) |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | SIMON NICHOLAS J III | Director | Buy | C | 0.00 | 1,571,267 | 0 | 1,571,267 | 0 to 1.6 M |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | SIMON NICHOLAS J III | Director | Buy | C | 0.00 | 4,402 | 0 | 4,402 | 0 to 4.4 K |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 580,518 | 0 | 0 | |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 1,125,077 | 0 | 0 | |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 1,571,267 | 0 | 0 | |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | EVNIN LUKE | 10% Owner | Buy | P | 10.00 | 300,000 | 3,000,000 | 3,576,862 | 3.3 M to 3.6 M (+9.16 %) |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 580,518 | 0 | 3,276,862 | 2.7 M to 3.3 M (+21.53 %) |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 1,125,077 | 0 | 2,696,344 | 1.6 M to 2.7 M (+71.60 %) |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 1,571,267 | 0 | 1,571,267 | 0 to 1.6 M |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | MPM BIOVENTURES III QP LP | 10% Owner | Option Exercise | C | 0.00 | 580,518 | 0 | 0 | |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | MPM BIOVENTURES III QP LP | 10% Owner | Option Exercise | C | 0.00 | 1,125,077 | 0 | 0 | |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | MPM BIOVENTURES III QP LP | 10% Owner | Option Exercise | C | 0.00 | 1,571,267 | 0 | 0 | |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | MPM BIOVENTURES III QP LP | 10% Owner | Buy | P | 10.00 | 300,000 | 3,000,000 | 3,576,862 | 3.3 M to 3.6 M (+9.16 %) |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | MPM BIOVENTURES III QP LP | 10% Owner | Buy | C | 0.00 | 580,518 | 0 | 3,276,862 | 2.7 M to 3.3 M (+21.53 %) |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | MPM BIOVENTURES III QP LP | 10% Owner | Buy | C | 0.00 | 1,125,077 | 0 | 2,696,344 | 1.6 M to 2.7 M (+71.60 %) |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | MPM BIOVENTURES III QP LP | 10% Owner | Buy | C | 0.00 | 1,571,267 | 0 | 1,571,267 | 0 to 1.6 M |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | Nomura Phase4 Ventures LTD | 10% Owner | Option Exercise | C | 0.00 | 433,633 | 0 | 0 | |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | Nomura Phase4 Ventures LTD | 10% Owner | Option Exercise | C | 0.00 | 2,014,098 | 0 | 0 | |
Nov 13 2007 | ARYX | ARYx Therapeutics, ... | Nomura Phase4 Ventures LTD | 10% Owner | Buy | C | 0.00 | 2,447,731 | 0 | 2,447,731 | 0 to 2.4 M |
Nov 09 2007 | ARYX | ARYx Therapeutics, ... | SIMON NICHOLAS J III | Director | Option Exercise | A | 8.10 | 16,666 | 134,995 | 16,666 | |
Nov 09 2007 | ARYX | ARYx Therapeutics, ... | Adelman Robert J | Director | Option Exercise | A | 8.10 | 16,666 | 134,995 | 16,666 | |
Nov 09 2007 | ARYX | ARYx Therapeutics, ... | Ekman Lars | Director | Option Exercise | A | 8.10 | 16,666 | 134,995 | 16,666 | |
Nov 09 2007 | ARYX | ARYx Therapeutics, ... | SEKHRI PAUL J | Director | Option Exercise | A | 8.10 | 16,666 | 134,995 | 16,666 | |
Nov 09 2007 | ARYX | ARYx Therapeutics, ... | Leonard Keith R | Director | Option Exercise | A | 8.10 | 16,666 | 134,995 | 16,666 | |
Nov 09 2007 | ARYX | ARYx Therapeutics, ... | ROSENMAN HERM | Director | Option Exercise | A | 8.10 | 16,666 | 134,995 | 16,666 |
Page: 1